Gedeon Richter
Pharma
Data as of 4 Oct 2026
Markdown version
Markdown version
Gedeon Richter was mentioned 2 times over the last 12 months; thepharmaletter.com alone carried 50% of that coverage.
MENTIONS · 12M
2
11 all-time
OUTLETS · 12M
2
in 1 countries
AVG SENTIMENT
Not enough coverage yet
Recent coverage
RICHTER Forecast — Price Target — Prediction for 2027 - TradingView
tradingview.com · INT · 25 Jun 2026 · neutral
Gedeon Richter gains FDA nod for biosimilar products - The Pharma Letter
thepharmaletter.com · INT · 6 Oct 2025 · positive
Share of voice among Pharma peers · 12m
| Brand | Mentions | Share |
|---|---|---|
| Eli lilly | 130 | 23% |
| Astrazeneca | 78 | 14% |
| Pfizer | 64 | 11% |
| Johnson & johnson | 59 | 10% |
| Novo nordisk | 46 | 8% |
| Merck | 44 | 8% |
| Sandoz | 41 | 7% |
| Moderna | 38 | 7% |
| Bayer | 36 | 6% |
| Roche | 36 | 6% |
Track Gedeon Richter against its rivals
Daily mentions, sentiment, share of voice and alerts — only what is actually about the brand.
Start trackingIs this your brand?
Claim the page to correct aliases, website or sector, and see the full picture.
Claim this page